Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 10, 2015
Patent Application Number
13651312
Date Filed
October 12, 2012
Patent Primary Examiner
Patent abstract
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
